AFP112-Semaglutide
0102030405
- +1 609-736-0910
- info@alphalifetech.com
- 90 State Street, STE 700 Office 40, Albany, NY 12207 United States
Product Background
In addition to its role in glycemic regulation, Semaglutide demonstrates high efficacy in weight reduction by crossing the blood-brain barrier to target satiety centers. It effectively lowers the "set point" for body weight by reducing energy intake and food cravings. By modulating both the homeostatic and hedonic pathways of eating behavior, Semaglutide provides a robust physiological approach to treating obesity and its associated metabolic comorbidities.
Catalog Number |
AFP112 |
Product Name |
AFP112-Semaglutide |
Molecular Formula |
C₁₈₇H₂₉₁N₄₅O₅₉ |
Molecular Weight |
4113.58 Da |
Structural formula |
H-H-Aib-Q-G-T-F-T-S-N-Y-S-Y-L-E-K(AEEA-AEEA-γGlu-C18 diacid)
-A-Q-Aib-A-F-I-E-Y-L-L-E-G-G-P-S-S-G-A-P-P-P-S-NH2
|
CAS Accession |
910463-68-2 |
Size |
1mg, 5mg, 100mg, bulk |
Storage Condition |
Cool dry place(-20±5℃,Keep away from acids and alkali) |
Purity |
>98% |
Purification |
HPLC |
Endotoxin |
< 5 EU/mg |
Reconstitution Conditions |
Reconstitute in ddH₂O for a stock solution. |
Shipping Condition |
This product is shipped on ice packs. |
Note |
For Research Use Only! |






